Search Results - "MOUILLAC, B."

Refine Results
  1. 1

    Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics by Manning, M., Misicka, A., Olma, A., Bankowski, K., Stoev, S., Chini, B., Durroux, T., Mouillac, B., Corbani, M., Guillon, G.

    Published in Journal of neuroendocrinology (01-04-2012)
    “…We recently reviewed the status of peptide and nonpeptide agonists and antagonists for the V1a, V1b and V2 receptors for arginine vasopressin (AVP) and the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes by Cottet, M, Albizu, L, Perkovska, S, Jean-Alphonse, F, Rahmeh, R, Orcel, H, Méjean, C, Granier, S, Mendre, C, Mouillac, B, Durroux, T

    Published in Current opinion in pharmacology (01-02-2010)
    “…The G protein-coupled receptors (GPCRs) play a major role in the regulation of physiological function. The emergence of the concept of GPCR oligomerization…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies by Mouillac, B, Manning, M, Durroux, T

    Published in Mini reviews in medicinal chemistry (01-09-2008)
    “…Different series of fluorescent agonists and antagonists have been developed and characterized for arginine-vasopressin and oxytocin G protein-coupled…”
    Get more information
    Journal Article
  6. 6

    Cloning, expression and pharmacological characterization of a vasopressin-related receptor in an annelid, the leech Theromyzon tessulatum by Levoye, A, Mouillac, B, Rivière, G, Vieau, D, Salzet, M, Breton, C

    Published in Journal of endocrinology (01-01-2005)
    “…In annelids, it has been established that arginine-vasopressin (AVP)/oxytocin (OT) superfamily peptides are involved in the maintenance of water and…”
    Get full text
    Journal Article
  7. 7

    The Two NK-1 Binding Sites Correspond to Distinct, Independent, and Non-Interconvertible Receptor Conformational States As Confirmed by Plasmon-Waveguide Resonance Spectroscopy by Alves, Isabel D, Delaroche, Diane, Mouillac, Bernard, Salamon, Zdzislaw, Tollin, Gordon, Hruby, Victor J, Lavielle, Solange, Sagan, Sandrine

    Published in Biochemistry (Easton) (25-04-2006)
    “…Two nonstoichiometric ligand binding sites have been previously reported for the NK-1 receptor, with the use of classical methods (radioligand binding and…”
    Get full text
    Journal Article
  8. 8

    Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells by Mouillac, B, Caron, M, Bonin, H, Dennis, M, Bouvier, M

    Published in The Journal of biological chemistry (25-10-1992)
    “…The palmitoylation of the human beta 2-adrenergic receptor (beta 2-AR) was studied in recombinant baculovirus-infected insect Sf9 cells. At 48 h…”
    Get full text
    Journal Article
  9. 9

    Altered phosphorylation and desensitization patterns of a human beta 2‐adrenergic receptor lacking the palmitoylated Cys341 by Moffett, S., Mouillac, B., Bonin, H., Bouvier, M.

    Published in The EMBO journal (01-01-1993)
    “…Exposure of beta 2‐adrenergic receptors to agonists causes a rapid desensitization of the receptor‐stimulated adenylyl cyclase, associated with an increased…”
    Get full text
    Journal Article
  10. 10

    Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor by Chini, B., Mouillac, B., Ala, Y., Balestre, M.N., Trumpp‐Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard, S.

    Published in The EMBO journal (15-05-1995)
    “…Using a three‐dimensional model of G protein‐coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents by Manning, Maurice, Stoev, Stoytcho, Chini, Bice, Durroux, Thierry, Mouillac, Bernard, Guillon, Gilles

    Published in Progress in brain research (2008)
    “…Oxytocin (OT) and vasopressin (AVP) mediate their biological actions by acting on four known receptors: The OT (uterine) and the AVP V(1a) (vasopressor), V(1b)…”
    Get more information
    Journal Article
  13. 13

    Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex by Guillemette, G, Lamontagne, S, Boulay, G, Mouillac, B

    Published in Molecular pharmacology (01-03-1989)
    “…In a wide variety of cells, inositol-1,4,5-triphosphate is a second messenger that interacts with specific intracellular receptors and triggers the release of…”
    Get more information
    Journal Article
  14. 14

    Design, Synthesis and Pharmacological Characterization of a Potent Radioiodinated and Photoactivatable Peptidic Oxytocin Antagonist by Carnazzi, Eric, Aumelas, André, Mouillac, Bernard, Breton, Christophe, Guillou, Laurent, Barberis, Claude, Seyer, René

    Published in Journal of medicinal chemistry (30-08-2001)
    “…Using a segment strategy, we have synthesized four iodinated photoactivatable cyclic peptidic ligands of oxytocin, bearing a β-mercapto-ββ-cyclopentamethylene…”
    Get full text
    Journal Article
  15. 15

    Structure of the vasopressin hormone-V2 receptor-β-arrestin1 ternary complex by Bous, Julien, Fouillen, Aurélien, Orcel, Hélène, Trapani, Stefano, Cong, Xiaojing, Fontanel, Simon, Saint-Paul, Julie, Lai-Kee-Him, Joséphine, Urbach, Serge, Sibille, Nathalie, Sounier, Rémy, Granier, Sébastien, Mouillac, Bernard, Bron, Patrick

    Published in Science advances (02-09-2022)
    “…Arrestins interact with G protein-coupled receptors (GPCRs) to stop G protein activation and to initiate key signaling pathways. Recent structural studies shed…”
    Get full text
    Journal Article
  16. 16

    Genomic and non-genomic mechanisms of oxytocin receptor regulation by Zingg, H H, Grazzini, E, Breton, C, Larcher, A, Rozen, F, Russo, C, Guillon, G, Mouillac, B

    “…Our recent studies have shown that regulation of uterine oxytocin (OT) binding involves at least two different mechanism: Estradiol (E2)-induced upregulation…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors by Fouillen, Aurélien, Bous, Julien, Granier, Sébastien, Mouillac, Bernard, Sounier, Remy

    Published in Membranes (Basel) (16-06-2023)
    “…G-protein coupled receptors (GPCRs) are versatile signaling proteins that regulate key physiological processes in response to a wide variety of extracellular…”
    Get full text
    Journal Article
  19. 19

    Functional Architecture of Vasopressin/Oxytocin Receptors by Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Mouillac, B., Chini, B., Mahea, E., Cotte, N., Jard, S., Manning, M., Barberis, C.

    “…Abstract Three-dimensional models of G protein-coupled receptors (GPCR) have been defined using most experimental data available and protein modeling…”
    Get full text
    Journal Article
  20. 20

    Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis by Terrillon, Sonia, Durroux, Thierry, Mouillac, Bernard, Breit, Andreas, Ayoub, Mohammed A, Taulan, Magali, Jockers, Ralf, Barberis, Claude, Bouvier, Michel

    Published in Molecular endocrinology (Baltimore, Md.) (01-04-2003)
    “…G protein-coupled receptor (GPCR) oligomerization is a growing concept that has emerged from several studies suggesting that GPCRs can form both homo- and…”
    Get full text
    Journal Article